These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17224367)

  • 1. High-potency steroid use in children with vitiligo: a retrospective study.
    Kwinter J; Pelletier J; Khambalia A; Pope E
    J Am Acad Dermatol; 2007 Feb; 56(2):236-41. PubMed ID: 17224367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From basic research to the bedside: efficacy of topical treatment with pseudocatalase PC-KUS in 71 children with vitiligo.
    Schallreuter KU; Krüger C; Würfel BA; Panske A; Wood JM
    Int J Dermatol; 2008 Jul; 47(7):743-53. PubMed ID: 18613887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcipotriene and corticosteroid combination therapy for vitiligo.
    Travis LB; Silverberg NB
    Pediatr Dermatol; 2004; 21(4):495-8. PubMed ID: 15283800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical immunomodulators are effective for treatment of vitiligo.
    Choi CW; Chang SE; Bak H; Choi JH; Park HS; Huh CH; Kim CW; Kim SE; Mun SK; Kim BJ; Kim MN
    J Dermatol; 2008 Aug; 35(8):503-7. PubMed ID: 18789070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases.
    Silverberg NB; Lin P; Travis L; Farley-Li J; Mancini AJ; Wagner AM; Chamlin SL; Paller AS
    J Am Acad Dermatol; 2004 Nov; 51(5):760-6. PubMed ID: 15523355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of tarcrolimus cream 0.1% in the treatment of vitiligo.
    Xu AE; Zhang DM; Wei XD; Huang B; Lu LJ
    Int J Dermatol; 2009 Jan; 48(1):86-90. PubMed ID: 19126059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral dexamethasone pulse treatment for vitiligo.
    Radakovic-Fijan S; Fürnsinn-Friedl AM; Hönigsmann H; Tanew A
    J Am Acad Dermatol; 2001 May; 44(5):814-7. PubMed ID: 11312430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pimecrolimus cream in repigmentation of vitiligo.
    Seirafi H; Farnaghi F; Firooz A; Vasheghani-Farahani A; Alirezaie NS; Dowlati Y
    Dermatology; 2007; 214(3):253-9. PubMed ID: 17377388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo.
    Parsad D; Kanwar AJ; Kumar B
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):175-7. PubMed ID: 16441626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, randomized trial of 0.05% betamethasone vs. topical catalase/dismutase superoxide in vitiligo.
    Sanclemente G; Garcia JJ; Zuleta JJ; Diehl C; Correa C; Falabella R
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1359-64. PubMed ID: 18624857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical melagenine for repigmentation in twenty-two child patients with vitiligo on the scalp.
    Xu AE; Wei XD
    Chin Med J (Engl); 2004 Feb; 117(2):199-201. PubMed ID: 14975202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cushing's syndrome induced by misuse of moderate- to high-potency topical corticosteroids.
    Coureau B; Bussières JF; Tremblay S
    Ann Pharmacother; 2008 Dec; 42(12):1903-7. PubMed ID: 19017822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of safety and efficacy of topical prostaglandin E2 in treatment of vitiligo.
    Kapoor R; Phiske MM; Jerajani HR
    Br J Dermatol; 2009 Apr; 160(4):861-3. PubMed ID: 19014395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical pimecrolimus in the treatment of vitiligo.
    Boone B; Ongenae K; Van Geel N; Vernijns S; De Keyser S; Naeyaert JM
    Eur J Dermatol; 2007; 17(1):55-61. PubMed ID: 17324829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial.
    Radakovic S; Breier-Maly J; Konschitzky R; Kittler H; Sator P; Hoenigsmann H; Tanew A
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):951-3. PubMed ID: 19496898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of excimer laser (308 nm) for vitiligo at different body sites.
    Hofer A; Hassan AS; Legat FJ; Kerl H; Wolf P
    J Eur Acad Dermatol Venereol; 2006 May; 20(5):558-64. PubMed ID: 16684284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects.
    Lotti T; Buggiani G; Troiano M; Assad GB; Delescluse J; De Giorgi V; Hercogova J
    Dermatol Ther; 2008 Jul; 21 Suppl 1():S20-6. PubMed ID: 18727812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial comparing the effectiveness of 308-nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck.
    Sassi F; Cazzaniga S; Tessari G; Chatenoud L; Reseghetti A; Marchesi L; Girolomoni G; Naldi L
    Br J Dermatol; 2008 Nov; 159(5):1186-91. PubMed ID: 18717675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy, predictors of response, and long-term follow-up in patients with vitiligo treated with narrowband UVB phototherapy.
    Nicolaidou E; Antoniou C; Stratigos AJ; Stefanaki C; Katsambas AD
    J Am Acad Dermatol; 2007 Feb; 56(2):274-8. PubMed ID: 17224369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical pimecrolimus: a new horizon for vitiligo treatment?
    Sendur N; Karaman G; Saniç N; Savk E
    J Dermatolog Treat; 2006; 17(6):338-42. PubMed ID: 17853306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.